Reshaping Postpartum Follow-up

Sponsor
Medstar Health Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT06054841
Collaborator
(none)
240
1
2
21.3
11.3

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the impact of personalized postpartum follow-up cards on completion of postpartum health related tasks. The intervention will consist of a card given to patients at time of discharge. One side of the card will list the patient's name and a list of recommended postpartum follow-up appointments based on their diagnoses at the time of discharge. Participants will be randomized to this intervention or the control group, which will consist of standard education routinely given at discharge.

The primary endpoint will be the rate of completion of a postpartum blood pressure check or two hour glucose tolerance test, or both, depending on the patient's discharge diagnosis within the first year after discharge. The secondary endpoints will include establishing care with a primary care provider within the first year after delivery, or completion of postpartum pap smear or colposcopy, as indicated.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Postpartum follow up card
  • Other: Control
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Reshaping Postpartum Follow-up in Women With High Risk Pregnancies
Actual Study Start Date :
May 22, 2023
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Mar 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Follow up cards

Subjects will receive a personalized postpartum health card with recommendations for follow up based on their comorbid conditions in pregnancy. They will receive education about these comorbid conditions when they receive their cards.

Behavioral: Postpartum follow up card
The intervention will consist of a card given to patients at time of discharge. One side of the card will list the patient's name and a list of recommended postpartum follow-up appointments based on their diagnoses at the time of discharge. The back of the card will list relevant phone numbers to assist patients with scheduling.

Placebo Comparator: Standard education

Subjects will receive standard postpartum education as it is routinely performed by nurses prior to discharge.

Other: Control
No deviation from standard discharge education

Outcome Measures

Primary Outcome Measures

  1. Blood pressure check [6 months]

    Rate of attendance at a blood pressure check one week postpartum

  2. Two hour glucose tolerance test [6 months]

    Rate of completion of two hour glucose tolerance test at six weeks postpartum

Secondary Outcome Measures

  1. Cervical cancer screening [6 months]

    Rate of completion of postpartum pap smear or colposcopy as indication

  2. Primary care [6 months]

    Rate of attendance at visit with primary care provider for annual exam

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Subjects >=18 years of age

  • Ability to read English or Spanish

  • Delivered via vaginal delivery or c-section within the past 48 hours

  • Able to consent for themselves

Exclusion Criteria:
  • Received antepartum care at a facility outside of the Medstar system or plans to continue care with a facility outside of the Medstar system

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington Hospital Center Washington District of Columbia United States 20010

Sponsors and Collaborators

  • Medstar Health Research Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medstar Health Research Institute
ClinicalTrials.gov Identifier:
NCT06054841
Other Study ID Numbers:
  • STUDY00006037
First Posted:
Sep 26, 2023
Last Update Posted:
Sep 26, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medstar Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 26, 2023